Evaluating the Use of Dalbavancin for Off-Label Indications

(1) Background: Dalbavancin is a long-acting lipoglycopeptide antibiotic approved for skin and soft-tissue infections. Post-marketing experience suggests dalbavancin is being used for off-label indications that normally require long-term intravenous (IV) antibiotics; however, data assessing this off...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Katherine, Williamson, John, Luther, Vera, Stone, Tyler, Johnson, James, Gruss, Zachary, Russ-Friedman, Courtney, Ohl, Chris, Beardsley, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026399/
https://www.ncbi.nlm.nih.gov/pubmed/35447884
http://dx.doi.org/10.3390/idr14020032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026399/
https://www.ncbi.nlm.nih.gov/pubmed/35447884
http://dx.doi.org/10.3390/idr14020032

Ejemplares similares